INTRODUCTION
mouse and Alexa Fluor 488 goat anti-rabbit (Molecular Probes) and horseradish peroxidasecoupled goat anti-mouse and rabbit IgG antibodies were from Pierce.
Mammalian Expression Plasmids
Detailed information on the various constructs generated in this study is provided in the Supplementary Material.
Immunofluorescence Microscopy
The experimental conditions for fluorescence microscopy are given in the Supplementary Material.
Endoglycosidase H Digestion
Endoglycosidase H (Endo H; New England Biolabs) digestions were performed on A375P cell extracts after lysis in loading buffer (180 mM Tris-HCl, pH 6.8, 0.5% SDS, and 1% 2-mercaptoethanol; Figure 4 ), or after lysis in lysis buffer (80 mM Tris-HCl, pH 6.8, 1% SDS; Figure 5 ). Samples were denatured at 96°C for 15 min and then supplemented with 1/10 volume of 50 mM sodium citrate, pH 5.5, and treated with Endo H for 1 h at 37 °C.
Gradients
ER and Golgi membranes were fractionated on a continuous OPTIPREP gradient (AxisShield plc, Dundee, Scotland) using 25, 20, 15, 10, and 5% OPTIPREP. A375P cells or HeLa cells transfected with HA-tagged TMX4 were lysed in homogenization buffer (0.25 M sucrose, 10 mM HEPES-NaOH, pH 7.4, 1 mM EDTA) and passed 15 times through a ballbearing homogenizer (Isobiotec, Heidelberg, Germany) with 18 µm clearance. Cell debris and nuclei were pelleted by centrifugation at 1,000g for 10 min. The post-nuclear supernatant was overlayed onto the continuous gradient and centrifuged at 32,700 rpm for 3 h at 4°C. Six equal fractions were collected from the top of the gradient and precipitated with acetone. Fractions were probed on a Western blot for endogenous TMX4 and HA-TMX4, calnexin (marker for rER/mitochondria-associated membrane (MAM)), E-cadherin (plasma membrane), 14-3-3ζ (Golgi), and complex II (mitochondria).
AMS modification
A375P cells were soaked in buffer containing N-ethylmaleimide (NEM) before lysis to block free cysteines as described previously [16] . Subsequently, the cell extract was reduced with 10 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) for 15 min and treated with 15 mM 4-acetamido-4-maleimidylstilbene-2,2-disulfonic acid (AMS) for 1h at room temperature. After separation by SDS-PAGE, TMX4, TMX and TMX3 were visualized by Western blotting.
Membrane Association and Proteinase K Protection Assay
To study the membrane association of TMX4, HA-TMX4-transfected HeLa cells at 60% confluency were harvested, fractionated and extracted in sodium carbonate as previously described [11] . To determine the topology of TMX4, HeLa cells were transfected with constructs to express HA-TMX4, TMX4-myc or ERp57-HA. 12 h after transfection, the cells were pulsed overnight at 37 °C with 125 µCi [
35 S]-methionine/cysteine (PerkinElmer) in 0.5 ml starvation medium (Dulbecco's modified Eagle's medium without methionine and cystine from Sigma) with 1% FCS per 35-mm dish. After the pulse, dishes were transferred to ice where all further steps were performed. The cells were washed twice with PBS, scraped off with a rubber policeman in homogenization buffer (20 mM Hepes-NaOH pH 7.5, 0.25 M sucrose, 1 mM dithiothreitol (DTT)) and passed 10 times through a 27 gauge needle. After removal of cell debris by centrifugation at 300 g for 3 min at 4 °C, the supernatant was centrifuged at 25,000 g for 1 h at 4 °C. The pellet was resuspended in assay buffer (25 mM Tris-HCl, pH 8, 500 mM NaCl, 1 mM DTT) and treated with 60 µg/ml proteinase K (PK; Roche Molecular Biochemicals) on ice for 1 h in the presence or absence of 1% Triton X-100 (TX-100). After inhibition of proteinase K with 1 mM PMSF, detergent-free samples were A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
solubilized with 1% Triton X-100 before the epitope-tagged proteins were immunoprecipitated, separated by SDS-PAGE and visualized by autoradiography.
Immunoprecipitation
Lysates were centrifuged at 25,000 g for 30 min, and the supernatants were rotated for 2 h at 4 °C with 50 µl protein A-sepharose beads (GE Healthcare) preadsorbed with either 2 µl HA.11 or 2 µl 9E10. After washing with lysis buffer (100 mM sodium phosphate, pH 8, 1% Triton X-100) and 100 mM sodium phosphate pH 8.0, proteins were eluted from the beads by boiling in sample buffer.
RESULTS

The TMX4 sequence
We identified the human gene encoding TMX4 in a GenBank BLAST search using a consensus sequence for a thioredoxin-like domain at the NCBI website (www.ncbi.nlm.nih.gov). The open reading frame encodes a protein of 349 residues (39 kDa, pI=4.3) including a signal sequence for entry into the secretory pathway with a predicted cleavage site between residues 23 and 24 ( Figure 1 ). Sequence alignment with thioredoxinlike domains of known three-dimensional structure from PDI, ERp57 and ERp72 initially suggested that the TMX4 thioredoxin-like domain would cover residues 39 to 136. However, comparison to the NMR structure of the closely related TMX protein [17] , revealed that the TMX4 thioredoxin-like domain -like that of TMX -probably possesses an additional Cterminal α-helix and a short β-strand compared to a canonical thioredoxin fold (α 5 and β 6 in Figure 1B ). The thioredoxin-like domain is followed by a stretch of 41 residues preceeding a predicted transmembrane helix spanning residues 188-210 (see also Figure 6A ). The Cterminal region (residues 211-349) is highly negatively charged with 54 acidic residues and contains no classical ER-localization motif of the K(X)KXX type that targets many type I membrane proteins to the ER [18] .
Phylogenetic analysis of the TMX4 and TMX sequences
Sequence alignments with other members of the human PDI family revealed that TMX4 is most closely related to TMX. Specifically, the thioredoxin-like domains show 53% sequence identity. In contrast, the C-terminal region after the predicted transmembrane helix is considerably less well conserved, with the most obvious difference being the length (78 residues in TMX versus 139 residues in TMX4). Transcripts for both proteins are present in a variety of mammals, amphibia, fish and birds but not in plants and yeasts, as shown by database analysis (see also below).
To learn more about the evolutionary relationship between the two proteins, we subjected a variety of TMX and TMX4 sequences to phylogenetic analysis by the maximum likelihood method. The evolutionary tree was rooted using ERp57, a close homolog of PDI ( Figure 2 ). The proteins clustered in three main groups. The cluster shown at the bottom first diverged from a common ancestor and comprises organisms with only one TMX/TMX4 protein. One of these proteins is DPY-11 from C. elegans [19] . We reason that a gene duplication then gave rise to the paralogs TMX and TMX4 that cluster in separate groups. Since the branch lengths represent the number of sequence changes that occurred prior to the next level of separation, the longer branches in the TMX4 cluster indicate that this protein diverged more from the common ancestor than TMX. The results of our analysis were supported by the TreeFam database [20] , where the TMX/TMX4 phylogenetic tree structures into the same three groups as presented in Figure 2 .
Tissue distribution of TMX4
The EST-based expression profile of the NCBI Unigene cluster Hs. 169358 suggests a broad tissue distribution of TMX4. We first confirmed this result by examining the transcript levels in a variety of human tissues by Northern blotting ( Figure 3A A c c e p t e d M a n u s c r i p t
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probes for TMX4 were used to hybridize a commercial tissue Northern blot. By autoradiography, we detected a signal at the predicted size of 6.1 kb for the TMX4 transcript in all tissues tested, although with varying intensity. We further corroborated the broad tissue distribution using RT-PCR analysis to identify TMX4 transcripts in a series of cultured cell lines ( Figure 3B ). Next, we probed different human cell lines for the presence of TMX4 by Western blotting using our own polyclonal antibody (R504) raised against the cytosolic domain of TMX4 (see Figure S1 and Figure 4A for specificity of R504). We detected relatively low levels in common lines such as HeLa and HEK293 (data not shown). Instead, a number of melanoma cells contained higher amounts of the protein ( Figure 3C ) in good agreement with the RT-PCR analysis showing the transcript to be abundant in A375 and Meljuso cells, and the finding that TMX4 expression is almost 10-fold upregulated upon the transformation of melanocytes to melanoma cells [21] .
TMX4 is an N-glycosylated ER protein
The TMX4 sequence contains one consensus site for N-glycosylation on Asn46 ( Figure 1B) . To investigate the glycosylation status of endogenous TMX4, we performed Western blot analysis on lysates of A375P melanoma cells treated with Endo H, a glycosidase that removes high-mannose type sugars. The results showed that TMX4 contained a glycan sensitive to Endo H treatment ( Figure 4A ), as did the N-terminally HA-tagged protein HA-TMX4 when overexpressed in HeLa cells ( Figure S2 ). To experimentally verify the predicted ER localization of TMX4, we expressed HA-TMX4 in Vero cells. By immunofluorescence microscopy, HA-TMX4 showed a typical reticular ER stain and was found to colocalize with the ER marker calnexin (CNX) ( Figure 4B ). Moreover, we confirmed that endogenous TMX4 co-fractionated with CNX on an Optiprep gradient. Here, TMX4 showed a distribution that differed slightly from that of CNX ( Figure 4C ), most likely because CNX not only localizes to the rough ER but also to mitochondria-associated membranes (MAM) [22] .
The TMX4 active site is mainly oxidized in cells Knowledge about the cellular redox state of a given PDI is a prerequisite for further detailed analysis of its redox properties. To determine the oxidation state of endogenous TMX4, A375P cells were subjected to an alkylation procedure where free cysteines are modified with NEM and cysteines present in disulfides with AMS [16] . As a result of the size difference between the two reagents, the AMS-modified form has decreased gel mobility. On a Western blot for TMX4, we detected two bands corresponding to the oxidized and reduced forms of he active site ( Figure 5 , upper panel). For comparison, we also determined the redox states of TMX and TMX3 ( Figure 5 , middle and lower panels). The results showed that whereas TMX4 is primarily oxidized -as also seen for HA-TMX4 expressed in HeLa cells ( Figure  S3 ) -TMX is primarily reduced in accordance with recent findings in other cell lines [9] . As we have previously seen for TMX3 in a variety of cultured cells, this protein was also primarily reduced in the A375P cells [11, 16, 23] .
Membrane topology of TMX4
We next established that TMX4 is a membrane protein as predicted by the TMHMM algorithm [24] ( Figure 6A ). Isolated crude membranes from HeLa cells expressing HA-TMX4 were extracted with sodium carbonate at high pH, and soluble and membraneassociated proteins were separated by high-speed centrifugation and probed by Western blotting. HA-TMX4 was detected exclusively in the membrane fraction, just like the type I transmembrane protein CNX ( Figure 6B ). The soluble marker protein ERp57 partly fractionated in the insoluble fraction as previously observed for another soluble ER protein, calreticulin, and possibly due to the association with membrane proteins [11, 25] .
In addition to the transmembrane domain (residues 188-210), two other hydrophobic stretches were detected in TMX4 ( Figure 6A ). The first, at the very N-terminus, corresponded to the signal sequence. The second comprised residues 147-187, i.e. the region that links the thioredoxin-like domain to the transmembrane region. Since we could not rule out that this A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
linker region was also buried in the membrane, thereby creating a topology with both termini of TMX4 in the ER and a short cytosolic loop, we determined the membrane topology of TMX4 using a proteinase K protection assay ( Figure 6C ).
Crude membrane extracts from [ 35 S]-methionine/cysteine-labeled HeLa cells expressing HA-TMX4 were left untreated or treated with proteinase K, followed by immunoprecipitation of the expressed protein. The untreated sample showed a signal at the expected size for HA-TMX4 of ~45 kDa. Upon proteinase K treatment, the band shifted to 25 kDa, a size closely matching that of the 21 kDa expected for HA-TMX4 devoid of the Cterminal cytosolic region. When the ER membrane was solubilized by addition of Triton X-100, proteinase K gained access to the lumen and the signal disappeared. Thus, the HAtagged N-terminus was localized in the ER as expected from the presence of the N-glycan on Asn46. To examine the orientation of the C-terminus, we performed the proteinase K assay on HeLa cells expressing C-terminally myc-tagged TMX4. Here, the TMX4-myc signal disappeared almost completely even in the absence of detergent, showing that the myc-tagged C-terminus was not protected inside the ER. The soluble lumenal ERp57 protein was used as a control for membrane integrity. Taken together, the results demonstrated that TMX4 is an N-glycosylated type I transmembrane protein of the ER.
A non-classical sequence motif contributes to ER targeting of TMX4
Although TMX4 resides in the ER, it lacks a classical K(X)KXX-type ER-localization signal. In multiple sequence alignments of TMX4 we noticed an LRQR sequence conserved among species with only very few exceptions and located close to the C-terminus ( Figure 1B ). In a number of type II and multispanning membrane proteins a Φ/Ψ/R-R-X-R sequence, in which Φ/Ψ and X represent an aromatic/bulky hydrophobic and any residue, respectively, acts as an ER-localization signal. So far, only one type I membrane protein, the ER lectin VIPL, has been shown to harbor an Arg-based ER-localization motif [26] .
To test the possible involvement of the RQR sequence in the ER localization of TMX4, we produced two HA-tagged mutants ( Figure 7A ) -i) a truncation variant lacking the C-terminal 121 residues (Δtail), and ii) a mutant with the two arginines of the RQR sequence substituted by lysines (KQK). We also wanted to assess a possible influence of the lumenal region of TMX4 in localizing the protein to the ER. Since a construct comprising only the lumenal domain of TMX4 was unstable (half-life ∼30 min compared to >10 hours for the wildtype protein (data not shown)), a fusion protein containing the ER-lumenal part of TMX4 combined with the transmembrane and cytosolic regions of CD4 was made (CD4-tail; Figure  7A ). Here, CD4 was chosen as a fusion partner since it localizes to the plasma membrane and hence does not contain ER retention/retrieval information itself [27] .
After transfecting HeLa cells, we analyzed the cellular localization of the wildtype protein and the three mutants by confocal immunofluorescence microscopy. We found that, unlike the wildtype protein, HA-TMX4 lacking the cytosolic tail partially escaped the ER and reached the plasma membrane. The KQK and CD4-tail mutants showed the same staining pattern as the Δtail mutant, also being detected on the cell surface. In conclusion, the RQR sequence was necessary for complete retention of TMX4 fusion proteins in the ER, while neither the lumenal region of TMX4 nor the tail lacking RQR had this ability.
Most likely due to the continuous overexpression of protein, the steady-state localization of all TMX4 variants also included the ER. To clear out the newly synthesized TMX4 variants of the ER, we treated HeLa cells with cycloheximide (CHX), a drug that inhibits protein synthesis (data not shown). Unfortunately, this strategy proved unfeasible because export occurred so slowly that the prolonged CHX treatment induced apoptosis [28] . However, protein aggregation was probably not the cause for the partial ER localization since the immunofluorescence pictures showed no visible aggregates. Moreover, we analyzed the oligomeric state of HA-TMX4 by sucrose gradient velocity centrifugation and found no evidence for Triton X-100-insoluble high-molecular weight complexes ( Figure S3 ). We further ruled out that the plasma membrane localization of the TMX4 mutants was a result of overloading a retention/retrieval mechanism, because the expression levels of the various A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
constructs used were similar (data not shown). Taken together, we found that the RQR sequence in the C-terminal region contributes to the ER localization of HA-TMX4.
ER localization conferred by the TMX4 cytosolic tail depends on the RQR sequence
To further characterize the importance of the TMX4 RQR sequence, we created three new fusion proteins ( Figure 8A ). All were HA-tagged chimeras between the cytosolic tail of TMX4 and the lumenal region of CD4. Two fusion proteins contained the wildtype sequence for the cytosolic tail of TMX4 but differed with respect to the origin of the transmembrane domain (TMX4 or CD4), whereas the last chimera contained the CD4 lumenal and transmembrane domains fused to the KQK mutant of the TMX4 cytosolic tail.
The chimeras and wildtype HA-CD4 were transfected into HeLa cells that were analyzed by confocal immunofluorescence microscopy ( Figure 8B ). As expected, we found HA-CD4 strongly staining the plasma membrane. In contrast, the two CD4 chimeras fused to a wildtype TMX4 tail sequence did not reach the cell surface. The nature of the transmembrane domain -whether from CD4 or TMX4 -did not influence the localization pattern. However, the chimeric protein of HA-CD4 fused to the cytosolic tail of TMX4 containing the KQK mutation was clearly detected on the plasma membrane and showed a distribution very similar to wildtype HA-CD4. Overall, the results demonstrated that the cytosolic tail of TMX4 is sufficient for ER targeting and that the RQR sequence is required for this ability.
DISCUSSION
Here, we provide the first characterization of the novel transmembrane PDI-family member, TMX4. Using phylogenetic analysis we show that TMX4 and TMX are paralogs with closely related N-terminal ER-lumenal regions, including a single thioredoxin-like domain, but quite different C-terminal cytosolic tails. Our analysis revealed that an evolutionarily older version of the two proteins is the DPY-11 protein from C. elegans. In the worm, this protein is expressed exclusively in the hypodermis and is required for body and sensory organ morphogenesis [19] . Curiously, DPY-11 does not harbor the RQR motif but a KKTK sequence at the C-terminus, suggesting a different ER-localization mechanism than TMX4 and TMX. Also, human TMX cannot rescue a dpy-11 mutant in C. elegans [19] .
Human TMX4 and most of its orthologs contain a CPSC active-site sequence, and all TMX orthologs have a CPAC motif. These are unusual active-site sequences among the PDIs, where the CGHC sequence is the most common with 16 occurrences among 25 domains with a CXXC sequence, whereas only two other domains contain a CPXC sequence [4] . The enzymes with the common CGHC motif generally seem to have moderate reduction potentials that are neither especially oxidizing nor reducing with values around -160 mV, as measured for TMX3, ERp57 and PDI [11, [29] [30] [31] . The cellular redox state of these proteins and TMX is partially oxidized ( [9, 11, 16, 23] ; Fig. 5 ), but not nearly to the extent seen in TMX4. Since the active-site sequence motif of TMX is very similar to that of TMX4, it is, however, unlikely that the uncommon CPSC motif in TMX4 can account for the observed redox state. Rather, currently unknown features of the TMX4 sequence that influence the redox properties of the protein, or its cellular redox regulation set it apart from the other PDIfamily members investigated to date. While the unusually oxidized redox state of TMX4 could well have interesting functional implications, we do presently not know the exact cellular function of the protein, although it could potentially be involved in ER quality control like TMX [9] .
Neither TMX4 nor TMX contain a C-terminal K(X)KXX-type ER-retrieval signal. Using chimeric molecules with CD4 that normally localizes to the plasma membrane, we mapped the TMX4 ER-localization signal to the cytosolic tail. Here, we found that even the conservative substitution of the two arginines in the RQR motif by lysines resulted in partial surface expression of TMX4 (Figure 7) . Indeed, the RQR sequence constitutes a bona fide ER-localization signal as further supported by the requirement of the two arginines for ER localization of TMX4 chimeras with CD4. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
It is interesting to consider why TMX4 (and potentially TMX, which also harbors a conserved Arg-based sequence motif; Figure 1B ) uses an Arg-based signal and not the classical C-terminal K(X)KXX motif. It is now clear that both types of signals function by COPI-mediated retrieval to the ER although binding of the involved sequence motifs occurs through different COPI subunits [32, 33] . Both motifs can prevent forward transport of unassembled subunits until they are sterically hidden by oligomerization in the ER [34, 35] . However, unlike the K(X)KXX sequences that are mainly found in ER-resident proteins, Argbased signals are often present on multimeric proteins destined for the plasma membrane. In addition to masking by multimeric assembly, Arg-based motifs can be overcome by cytosolic interaction partners such as 14-3-3 proteins that promote cell surface expression of ion channels and receptors [36] [37] [38] . In the case of TMX4 (and TMX) suppression of the Argbased motif, potentially in response to specific cellular conditions, might therefore allow the relocalization of the protein.
Features in addition to the RQR motifs in TMX4 and TMX suggest that their trafficking could be regulated by multiple factors. The tails of both proteins contain a long stretch of negatively charged residues comprising two experimentally verified phosphorylation sites on serine residues 251 and 259 for TMX4 ( Figure 1B) , and on serine residues 247 and 253 for TMX [39] . The combination of these sequence features has been shown to constitute a potential binding site for PACS-2, a cytosolic sorting protein that uses COPI to target its substrate proteins to the ER dependent on their phosphorylation state [40, 41] . While speculative at present, it is conceivable that the subcellular localization and thereby the functions of TMX4 and TMX are modulated by binding (potentially phosphorylation-dependent) of regulatory sorting factors that target binding sites in the cytosolic tail. Tochio, N., Koshiba, S., Inoue, M., Kigawa, T. and Yokoyama, S. ID ENSG00000139921) . Black boxes represent amino acid identities and gray boxes show amino acid similarities. The following features are indicated above the sequence: Signal sequence (striped rectangle), Nglycosylation consensus site (asterisk), CPXC active-site sequence (double-headed arrow), transmembrane region (checkered rectangle), phosphorylation sites (hashes), and RQR motif (diamonds). Below the sequence, rectangles and arrows indicate α-helices and β-strands, respectively, corresponding to the positions of secondary structure elements in the NMR structure of the thioredoxin-like domain of TMX. 8 kb) . As a control, the blot was stripped and labeled against the β-actin transcript (2.0 kb with an additional 1.8 kb isoform in muscle tissues). (B) Semi-quantitative PCR on various cultured cell lines. A375: human melanoma; HEK293: human embryonic kidney; HeLa: cervical epithelial carcinoma; HepG2: hepatocellular carcinoma; CFPAC-1: pancreatic adeno carcinoma; Meljuso: melanoma; HT1080: fibrosarcoma breast cancer; OVCAR3, SKOV3: ovarian epithelial carcinoma; LRB003: embryonic stem cells. Total RNA was isolated, its concentration adjusted and mRNA reverse transcribed. A PCR was performed with forward and reverse primers specific for a region that spans two TMX4 exons (expected product size: 412 bp). A PCR with primers specific for actin was performed as a control. (C) Western blot analysis of extracts of the human melanoma cell lines M2, A375M, A375P, LT5-1 and DX3 with the polyclonal R504 antibody against TMX4. In the lower panel the actin signal is shown as a loading control. HA-TMX4 colocalizes with the ER marker calnexin (CNX) by confocal immunofluorescence microscopy. Vero cells were transfected with pcDNA3.1/HA-TMX4, fixed and analyzed by immunofluorescence microscopy using antibodies against the HA epitope and CNX. (C) OPTIPREP fractionation of TMX4 and organelle marker proteins. A375P (for endogenous TMX4) and HeLa cells transfected with HA-tagged TMX4 were lysed and cellular membranes were fractionated on a discontinuous OPTIPREP gradient. Fractions 1-6 were blotted with antibodies against the indicated marker proteins (calnexin (rER/mitochondria-associated membrane (MAM)), Ecadherin (cell surface), 14-3-3ζ (Golgi) and mitochondrial complex II (mitochondria)). A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
Following in situ blocking of free cysteines by NEM, A375P cell lysates were reduced by TCEP and treated with AMS, then separated by SDS-PAGE and finally analysed by Western blotting (WB). Cells were pretreated with 10 mM DTT and 5 mM diamide to obtain controls for the fully reduced (RED) and oxidized (OX) forms, respectively, of TMX4 (upper panel), TMX (middle panel) and TMX3 (lower panel). A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. H. s. H. s. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. A c c e p t e d M a n u s c r i p t
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